These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 24592497)

  • 1. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.
    Leening MJ; Vedder MM; Witteman JC; Pencina MJ; Steyerberg EW
    Ann Intern Med; 2014 Jan; 160(2):122-31. PubMed ID: 24592497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What to expect from net reclassification improvement with three categories.
    Pencina KM; Pencina MJ; D'Agostino RB
    Stat Med; 2014 Dec; 33(28):4975-87. PubMed ID: 25176621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A confidence ellipse for the Net Reclassification Improvement.
    Mühlenbruch K; Kuxhaus O; Pencina MJ; Boeing H; Liero H; Schulze MB
    Eur J Epidemiol; 2015 Apr; 30(4):299-304. PubMed ID: 25724473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of net reclassification index to non-nested and point-based risk prediction models: a review.
    Thomas LE; O'Brien EC; Piccini JP; D'Agostino RB; Pencina MJ
    Eur Heart J; 2019 Jun; 40(23):1880-1887. PubMed ID: 29955849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].
    Steyerberg EW; Pencina MJ; Van Calster B
    Ned Tijdschr Geneeskd; 2012; 156(41):A5029. PubMed ID: 23062255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Net Reclassification Improvement for Nonnested Models and a Novel Percentile-Based Alternative.
    McKearnan SB; Wolfson J; Vock DM; Vazquez-Benitez G; O'Connor PJ
    Am J Epidemiol; 2018 Jun; 187(6):1327-1335. PubMed ID: 29304237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
    Pencina MJ; D'Agostino RB; Steyerberg EW
    Stat Med; 2011 Jan; 30(1):11-21. PubMed ID: 21204120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net Reclassification Index Statistics Do Not Help Assess New Risk Models.
    Kerr KF
    Radiology; 2023 Mar; 306(3):e222343. PubMed ID: 36378029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining risk markers improves cardiovascular risk prediction in women.
    Holewijn S; den Heijer M; Kiemeney LA; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2014 Jan; 126(2):139-46. PubMed ID: 23879211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Net Reclassification Improvement.
    Jewell ES; Maile MD; Engoren M; Elliott M
    Anesth Analg; 2016 Mar; 122(3):818-824. PubMed ID: 26891393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.
    Martens FK; Tonk ECM; Janssens ACJW
    Genet Med; 2019 Feb; 21(2):391-397. PubMed ID: 29895851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets.
    Pepe MS; Fan J; Feng Z; Gerds T; Hilden J
    Stat Biosci; 2015 Oct; 7(2):282-295. PubMed ID: 26504496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of reclassification for assessment of improved prediction: an empirical evaluation.
    Tzoulaki I; Liberopoulos G; Ioannidis JP
    Int J Epidemiol; 2011 Aug; 40(4):1094-105. PubMed ID: 21325392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems with risk reclassification methods for evaluating prediction models.
    Pepe MS
    Am J Epidemiol; 2011 Jun; 173(11):1327-35. PubMed ID: 21555714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination.
    Sundström J; Byberg L; Gedeborg R; Michaëlsson K; Berglund L
    Scand J Public Health; 2011 Jun; 39(4):439-41. PubMed ID: 21270137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.